SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at SITC 2026

The company says the Phase 2 AMPLIFY-7P results will be presented in a keynote/plenary session and late-breaking poster at the SITC 2026 Annual Meeting.

ELTX

Related stories